Cargando…

Regulating the BCL2 Family to Improve Sensitivity to Microtubule Targeting Agents

Chemotherapeutic targeting of microtubules has been the standard of care in treating a variety of malignancies for decades. During mitosis, increased microtubule dynamics are necessary for mitotic spindle formation and successful chromosomal segregation. Microtubule targeting agents (MTAs) disrupt t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitaker, Robert H., Placzek, William J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523793/ https://www.ncbi.nlm.nih.gov/pubmed/31013740 http://dx.doi.org/10.3390/cells8040346

Ejemplares similares

Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members
por: Cui, Jia, et al.
Publicado: (2018)

Glioma Stem Cells Are Sensitized to BCL-2 Family Inhibition by Compromising Histone Deacetylases
por: Merati, Aran, et al.
Publicado: (2023)

Novel microtubule-targeting agents – the epothilones
por: Cheng, Kit L, et al.
Publicado: (2008)

Bcl-B: an “unknown” protein of the Bcl-2 family
por: Pervushin, N. V., et al.
Publicado: (2023)

Targeting BCL-2 regulated apoptosis in cancer
por: Campbell, Kirsteen J., et al.
Publicado: (2018)

New dimension in therapeutic targeting of BCL-2 family proteins
por: Besbes, Samaher, et al.
Publicado: (2015)

BCL-2 protein family: attractive targets for cancer therapy
por: Kaloni, Deeksha, et al.
Publicado: (2022)

Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma
por: Loong, Herbert H, et al.
Publicado: (2014)

Beyond taxanes: the next generation of microtubule-targeting agents
por: Cortes, Javier, et al.
Publicado: (2011)

Inhibition of kinesin family member 20B sensitizes hepatocellular carcinoma cell to microtubule‐targeting agents by blocking cytokinesis
por: Liu, Xinran, et al.
Publicado: (2018)

BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies
por: Bogenberger, J M, et al.
Publicado: (2014)

Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
por: Wordeman, Linda, et al.
Publicado: (2021)

Intrinsically Connected: Therapeutically Targeting the Cathepsin Proteases and the Bcl-2 Family of Protein Substrates as Co-regulators of Apoptosis
por: Soond, Surinder M., et al.
Publicado: (2021)

Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors
por: Zhu, Yi, et al.
Publicado: (2016)

BCL-W is a regulator of microtubule inhibitor-induced mitotic cell death
por: Huang, Shan, et al.
Publicado: (2016)

Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
por: de Jong, Yvonne, et al.
Publicado: (2018)

The Bcl-2 Family in Host-Virus Interactions
por: Kvansakul, Marc, et al.
Publicado: (2017)

VDAC2 and the BCL-2 family of proteins
por: Yuan, Zheng, et al.
Publicado: (2021)

Therapeutic Modulation of Apoptosis: Targeting the BCL-2 Family at the Interface of the Mitochondrial Membrane
por: Nemec, Kathleen N., et al.
Publicado: (2008)

Targeting the Bcl-2 Family in B Cell Lymphoma
por: Adams, Clare M., et al.
Publicado: (2019)

Taxol(®): The First Microtubule Stabilizing Agent
por: Yang, Chia-Ping Huang, et al.
Publicado: (2017)

Bcl-2 family inhibitors sensitize human cancer models to therapy
por: Valentini, Elisabetta, et al.
Publicado: (2023)

The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias
por: Tzifi, Flora, et al.
Publicado: (2012)

Role of Bcl-2 Family Proteins in Photodynamic Therapy Mediated Cell Survival and Regulation
por: Aniogo, Eric Chekwube, et al.
Publicado: (2020)

Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism
por: Markowitz, Daniel, et al.
Publicado: (2017)

Regulation of the Adaptive Immune Response by the IκB Family Protein Bcl-3
por: Herrington, Felicity D., et al.
Publicado: (2016)

BCL-2 family isoforms in apoptosis and cancer
por: Warren, Chloe F. A., et al.
Publicado: (2019)

BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma
por: Gupta, Vikas A, et al.
Publicado: (2021)

Anti-apoptotic BCL-2 family members in development
por: Opferman, Joseph T, et al.
Publicado: (2018)

The Mysteries around the BCL-2 Family Member BOK
por: Shalaby, Raed, et al.
Publicado: (2020)

New Quinoline-Based Heterocycles as Anticancer Agents Targeting Bcl-2
por: Hamdy, Rania, et al.
Publicado: (2019)

New Bioactive Fused Triazolothiadiazoles as Bcl-2-Targeted Anticancer Agents
por: Hamdy, Rania, et al.
Publicado: (2021)

MCL1 binding to the reverse BH3 motif of P18INK4C couples cell survival to cell proliferation
por: Whitaker, Robert H., et al.
Publicado: (2020)

Targeting the BCL-2-regulated apoptotic pathway for the treatment of solid cancers
por: Fairlie, W. Douglas, et al.
Publicado: (2021)

The Role of Bcl-2 Family Proteins in Therapy Responses of Malignant Astrocytic Gliomas: Bcl2L12 and Beyond
por: Kouri, Fotini M., et al.
Publicado: (2012)

Neuronal cell life, death, and axonal degeneration as regulated by the BCL-2 family proteins
por: Pemberton, James M., et al.
Publicado: (2020)

Inhibiting microcephaly genes as alternative to microtubule targeting agents to treat brain tumors
por: Iegiani, Giorgia, et al.
Publicado: (2021)

Recent Approaches to the Identification of Novel Microtubule-Targeting Agents
por: Eli, Susanna, et al.
Publicado: (2022)

MCL1 binds and negatively regulates the transcriptional function of tumor suppressor p73
por: Widden, Hayley, et al.
Publicado: (2020)

BCL-2 as therapeutic target for hematological malignancies
por: Perini, Guilherme Fleury, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7p7p05nrf3bi8ht146spbgdc6d